However, the expression levels of PD-1 and CD38 were significantly elevated in CX3CR1+CD4+ T cells in the D2T RA group compared with non-D2T RA group (Fig. 6c), suggesting these molecules as treatment-resistant T cell subset markers. This evidence concerns the gene CD4 and rheumatoid arthritis.